Fig. 2
From: Prevalence of Helicobacter pylori infection in patients with chronic hepatitis C
Quantification of H. pylori antigen in addition to its observed fold changes in serum of chronic hepatitis C patients (a). The levels of 58-kDa H. pylori antigen among different METAVIR fibrosis stages (b, c, d). The distribution of observed fold changes for 58-kDa H. pylori antigen among different METAVIR fibrosis stages (e). Prevalence of 58-kDa H. pylori antigen among patients with liver fibrosis and cirrhosis showing an increase in its detection rate with the progression of liver pathology (f). Scatter plot showing the distribution of 58-kDa H. pylori antigen with the progression of liver fibrosis. P > 0.05 is considered non-significant, P < 0.05 is considered significant, and P < 0.0001 is considered extremely significant